121 related articles for article (PubMed ID: 36084428)
1. Transcriptional level evaluation of osteopontin/miRNA-181a axis in hepatocellular carcinoma cell line-secreted extracellular vesicles.
Cabiati M; Di Giorgi N; Salvadori C; Finamore F; Del Turco S; Cecchettini A; Rocchiccioli S; Del Ry S
Pathol Res Pract; 2022 Oct; 238():154088. PubMed ID: 36084428
[TBL] [Abstract][Full Text] [Related]
2. miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles.
Cabiati M; Salvadori C; Basta G; Del Turco S; Aretini P; Cecchettini A; Del Ry S
Clin Exp Med; 2022 May; 22(2):245-255. PubMed ID: 34319456
[TBL] [Abstract][Full Text] [Related]
3. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
Bhattacharya SD; Garrison J; Guo H; Mi Z; Markovic J; Kim VM; Kuo PC
Surgery; 2010 Aug; 148(2):291-7. PubMed ID: 20576283
[TBL] [Abstract][Full Text] [Related]
4. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of adrenomedullin and its specific receptors in liver tissues from patients with hepatocellular carcinoma and in tumorigenic cell line-secreted extracellular vesicles.
Cabiati M; Gaggini M; De Simone P; Salvadori C; Del Turco S; Caselli C; Cecchettini A; Del Ry S
Pathol Res Pract; 2023 Mar; 243():154383. PubMed ID: 36827885
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.
Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976
[TBL] [Abstract][Full Text] [Related]
7. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.
Emani S; Zhang J; Guo L; Guo H; Kuo PC
Surgery; 2008 Jun; 143(6):803-12. PubMed ID: 18549897
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up.
Cabiati M; Gaggini M; Cesare MM; Caselli C; De Simone P; Filipponi F; Basta G; Gastaldelli A; Del Ry S
Cytokine; 2017 Nov; 99():59-65. PubMed ID: 28711012
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.
Phillips RJ; Helbig KJ; Van der Hoek KH; Seth D; Beard MR
World J Gastroenterol; 2012 Jul; 18(26):3389-99. PubMed ID: 22807608
[TBL] [Abstract][Full Text] [Related]
10. Aging and biomarkers: Transcriptional levels evaluation of Osteopontin/miRNA-181a axis in hepatic tissue of rats in different age ranges.
Cabiati M; Salvadori C; Sapio A; Burchielli S; Carlucci L; Moscato S; Sabatino L; Caselli C; Mattii L; Del Ry S
Exp Gerontol; 2020 May; 133():110879. PubMed ID: 32061643
[TBL] [Abstract][Full Text] [Related]
11. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines.
Chae S; Jun HO; Lee EG; Yang SJ; Lee DC; Jung JK; Park KC; Yeom YI; Kim KW
Int J Oncol; 2009 Dec; 35(6):1409-16. PubMed ID: 19885563
[TBL] [Abstract][Full Text] [Related]
13. Measuring levels of osteopontin as potential biomarker for hepatocellular carcinoma in Syrian patients.
Al-Zoubi S; Wassouf A; Zetoune AB
Gastroenterol Hepatol Bed Bench; 2017; 10(2):97-101. PubMed ID: 28702132
[TBL] [Abstract][Full Text] [Related]
14. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
[TBL] [Abstract][Full Text] [Related]
15. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma.
Liu W; Xu G; Ma J; Jia W; Li J; Chen K; Wang W; Hao C; Wang Y; Wang X
Tohoku J Exp Med; 2011 May; 224(1):29-39. PubMed ID: 21512310
[TBL] [Abstract][Full Text] [Related]
19. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.
Yang Y; Mao F; Guo L; Shi J; Wu M; Cheng S; Guo W
Dig Liver Dis; 2021 Apr; 53(4):474-485. PubMed ID: 33563583
[TBL] [Abstract][Full Text] [Related]
20. Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
Shang S; Plymoth A; Ge S; Feng Z; Rosen HR; Sangrajrang S; Hainaut P; Marrero JA; Beretta L
Hepatology; 2012 Feb; 55(2):483-90. PubMed ID: 21953299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
